| Literature DB >> 24966912 |
Yasunobu Matsuda1, Ayumi Sanpei2, Toshifumi Wakai2, Masayuki Kubota3, Mami Osawa3, Yuki Hirose2, Jun Sakata2, Takashi Kobayashi2, Shun Fujimaki1, Masaaki Takamura4, Satoshi Yamagiwa4, Masahiko Yano4, Shogo Ohkoshi4, Yutaka Aoyagi4.
Abstract
Hepatitis B virus X (HBX) protein plays a crucial role in carcinogenesis, but its mechanism is unclear. The involvement of ataxia telangiectasia mutated (ATM) kinase in the enhanced redox system was investigated by examining the phosphorylation level of ATM in HBX gene-transfected cells and in transgenic mice following redox system manipulation by treatment with hydrogen peroxide (H2O2) or antioxidant. Western blotting and immunostaining showed that phospho-ATM was significantly increased by HBX both in vitro (3.2-fold; p<0.05) and in vivo (4-fold; p<0.05), and this effect was abrogated by antioxidant treatment. The level of PKC-δ in HBX-expressing cells was increased 3.5-fold compared to controls. Nuclear localized NF-E2-related factor 2 (Nrf2) was increased in HBX-expressing cells exposed to H2O2, but remained at lower levels after the treatment with rottlerin, KU55933, or caffeine. The levels of anti-oxidant molecules were increased in HBX expressing cells and in transgenic mice, indicating that HBX stimulates the Nrf2-mediated redox system. The levels of intracellular reactive oxygen species (ROS) were significantly increased in HBX-expressing cells treated with hydrogen peroxide in the presence of ATM inhibitor KU55933 or caffeine. Treatment of HBX-expressing cells with KU55933 or caffeine before the exposure to H2O2 increased the ratio of cell apoptosis to 33±4% (p<0.05) and 22±4% (p<0.05), respectively. Collectively, HBX stimulates the ATM-mediated PKC-δ/Nrf2 pathway, and maintains the enhanced activity of the redox system. Therefore, manipulating ATM kinase activity might be a useful strategy for treating HBX-induced carcinogenesis.Entities:
Keywords: Hepatitis B virus X; ataxia telangiectasia mutated; reactive oxygen species
Mesh:
Substances:
Year: 2014 PMID: 24966912 PMCID: PMC4069949
Source DB: PubMed Journal: Int J Clin Exp Pathol ISSN: 1936-2625